A Drug-drug Interaction Study With TS-172 in Healthy Adult Male Subjects

Clinical trial NCT06837142 · COMPLETED

Trial details

NCT number: NCT06837142
Sponsor: Taisho Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male Subjects

Start date: 2025-03-11
Primary completion: 2025-04-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.